PCNA and osteosarcoma: Thus, the identification of osteosarcoma prognostic markers and therapeutic targets is an urgent requirement.[7] Recently, several common markers[8,9] have been identified correlated with the metastasis and prognosis in osteosarcoma, and proliferating cell nuclear antigen (PCNA) is a promising marker among these.